-
Categories
-
Pharmaceutical Intermediates
-
Active Pharmaceutical Ingredients
-
Food Additives
- Industrial Coatings
- Agrochemicals
- Dyes and Pigments
- Surfactant
- Flavors and Fragrances
- Chemical Reagents
- Catalyst and Auxiliary
- Natural Products
- Inorganic Chemistry
-
Organic Chemistry
-
Biochemical Engineering
- Analytical Chemistry
-
Cosmetic Ingredient
- Water Treatment Chemical
-
Pharmaceutical Intermediates
Promotion
ECHEMI Mall
Wholesale
Weekly Price
Exhibition
News
-
Trade Service
On February 14, Renfu Pharmaceutical announced that its holding subsidiary, Yichang Renfu, has recently received the "Drug Registration Certificate" for Memantine Hydrochloride Sustained-Release Capsules approved and issued by the State Drug Administration for the treatment of moderate to severe cases.
Yichang Renfu's Memantine Hydrochloride Sustained-Release Capsules was approved by the FDA in April 2021, and the registration application for the drug was submitted to the State Drug Administration in April 2020 and was accepted.